S

Sangamo Therapeutics
D

SGMO

1.10000
USD
-0.01
(-0.45%)
مغلق
حجم التداول
101,902
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
229,511,557
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    B
    BMRN
    0.260
    (0.42%)
    61.570 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    المزيد
الأخبار
المقالات

العنوان: Sangamo Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.